Frontiers in Pediatrics (Sep 2022)

High detection rate for disease-causing variants in a cohort of 30 Iranian pediatric steroid resistant nephrotic syndrome cases

  • Maryam Najafi,
  • Maryam Najafi,
  • Korbinian M. Riedhammer,
  • Korbinian M. Riedhammer,
  • Aboulfazl Rad,
  • Aboulfazl Rad,
  • Paria Najarzadeh Torbati,
  • Riccardo Berutti,
  • Isabel Schüle,
  • Sophie Schroda,
  • Thomas Meitinger,
  • Jasmina Ćomić,
  • Jasmina Ćomić,
  • Simin Sadeghi Bojd,
  • Tayebeh Baranzehi,
  • Azadeh Shojaei,
  • Anoush Azarfar,
  • Mahmood Reza Khazaei,
  • Anna Köttgen,
  • Anna Köttgen,
  • Rolf Backofen,
  • Rolf Backofen,
  • Ehsan Ghayoor Karimiani,
  • Ehsan Ghayoor Karimiani,
  • Julia Hoefele,
  • Miriam Schmidts,
  • Miriam Schmidts,
  • Miriam Schmidts

DOI
https://doi.org/10.3389/fped.2022.974840
Journal volume & issue
Vol. 10

Abstract

Read online

BackgroundSteroid resistant nephrotic syndrome (SRNS) represents a significant renal disease burden in childhood and adolescence. In contrast to steroid sensitive nephrotic syndrome (SSNS), renal outcomes are significantly poorer in SRNS. Over the past decade, extensive genetic heterogeneity has become evident while disease-causing variants are still only identified in 30% of cases in previously reported studies with proportion and type of variants identified differing depending on the age of onset and ethnical background of probands. A genetic diagnosis however can have implications regarding clinical management, including kidney transplantation, extrarenal disease manifestations, and, in some cases, even causal therapy. Genetic diagnostics therefore play an important role for the clinical care of SRNS affected individuals.Methodology and resultsHere, we performed NPHS2 Sanger sequencing and subsequent exome sequencing in 30 consanguineous Iranian families with a child affected by SRNS with a mean age of onset of 16 months. We identified disease-causing variants and one variant of uncertain significance in 22 families (73%), including variants in NPHS1 (30%), followed by NPHS2 (20%), WT1 (7%) as well as in NUP205, COQ6, ARHGDIA, SGPL1, and NPHP1 in single cases. Eight of these variants have not previously been reported as disease-causing, including four NPHS1 variants and one variant in NPHS2, ARHGDIA, SGPL1, and NPHP1 each.ConclusionIn line with previous studies in non-Iranian subjects, we most frequently identified disease-causing variants in NPHS1 and NPHS2. While Sanger sequencing of NPHS2 can be considered as first diagnostic step in non-congenital cases, the genetic heterogeneity underlying SRNS renders next-generation sequencing based diagnostics as the most efficient genetic screening method. In accordance with the mainly autosomal recessive inheritance pattern, diagnostic yield can be significantly higher in consanguineous than in outbred populations.

Keywords